Sisram Medical Issues RSUs to Retain Top Talent

Sisram Medical Ltd. (HK:1696) has released an update.

Sisram Medical Ltd has announced the grant of 1,320,300 restricted share units (RSUs) to 59 employees under its 2021 RSU Scheme, with the aim of retaining core talent and supporting long-term growth. The RSUs, which are subject to performance conditions and vest 12 months from the grant date, were issued at no cost to the recipients. This strategic move is designed to incentivize employees and align their interests with those of the company and its shareholders.

For further insights into HK:1696 stock, check out TipRanks’ Stock Analysis page.